Poster
Aude Geistodt-Kiener
Universite Paris-Saclay, INRAE, UR BIOGER
Palaiseau, Ile-de-France, France
Jean Chrisologue Totozafy
Universite Paris-Saclay, INRAE, AgroParisTech, IJPB
Versailles, Ile-de-France, France
Géraldine Le Goff
Universite Paris-Saclay, CNRS, ICSN
Gif-sur-Yvette, Ile-de-France, France
Kaori Sakai
Universite Paris-Saclay, INRAE, UR BIOGER
Palaiseau, Ile-de-France, France
Muriel Viaud
Group Leader team ECCP
Universite Paris-Saclay, INRAE, UR BIOGER
Palaiseau, Ile-de-France, France
Richard J. O'Connell
Scientific Advisor of IMAFUN
Université Paris-Saclay, INRAE, UR BIOGER
Palaiseau, Ile-de-France, France
Jean-Felix Dallery
Group Leader
Universite Paris-Saclay, INRAE, UR BIOGER
Palaiseau
Fungal pathogens of plants activate the expression of numerous biosynthetic gene clusters (BGC) exclusively when in the presence of a living host plant. This is a major bottleneck to the identification and structural elucidation of the corresponding fungal secondary metabolites. The heterologous expression of BGCs in microbial cell factories is one of the many approaches to get around such obstacles. We have implemented a system based on different Saccharomyces cerevisiae chassis strains and polycistronic vectors for efficient, seamless and cost-effective cloning of biosynthetic genes using in vivo assembly (also called transformation-assisted recombination) directly in Escherichia coli. Polycistrons were placed under the control of auto-inducible yeast promoters, pADH2 and pPCK1. As a proof-of-concept, we applied our system to the Colletochlorins, a family of phytotoxic molecules produced by Colletotrichum higginsianum. Using comparative genomics, we identified a BGC putatively involved in the biosynthesis of Colletochlorins in C. higginsianum, the causal agent of anthracnose disease of Brassicaceae. Expression of those genes in S. cerevisiae resulted in the identification of the precursor Orsellinic acid, Colletochlorins and their non-chlorinated counterparts, the Colletorins and allowed to link these compounds to their corresponding BGC. This system will now enable the production and purification of infection-specific secondary metabolites of fungal phytopathogens.